Organization
BrainX
1 clinical trial
Clinical trial
A Randomized, Double Blinded, Placebo-controlled Phase II Study to Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease DementiaStatus: Recruiting, Estimated PCD: 2024-12-31